Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Tromp

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
Science Translational Medicine|November 10, 2017
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAHAtze van der Pol, Andres Gil, Herman H W Silljé, et al.
ESC Heart Failure|April 1, 2018
Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fractionVera J Goh, Jasper Tromp, Tiew-Hwa K Teng, et al.
European Journal of Heart Failure|April 4, 2020
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failureIziah E Sama, Rebecca J Woolley, Jan F Nauta, et al.
European Journal of Heart Failure|February 5, 2024
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approachBart J van Essen, Ganash N Tharshana, Wouter Ouwerkerk, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2025
Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart FailureKees H van Bergeijk, Constantijn S Venema, Bob Ophuis, et al.
European Journal of Heart Failure|September 10, 2023
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF modelPascal M Burger, Gianluigi Savarese, Jasper Tromp, et al.
Circulation. Heart Failure|April 16, 2024
Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry ScienceAnubha Agarwal, Jasper Tromp, Wael Almahmeed, et al.
European Journal of Heart Failure|August 9, 2024
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registryThong Huy Cao, Wan Ting Tay, Donald J L Jones, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
Science Translational Medicine|November 10, 2017
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAHAtze van der Pol, Andres Gil, Herman H W Silljé, et al.
ESC Heart Failure|April 1, 2018
Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fractionVera J Goh, Jasper Tromp, Tiew-Hwa K Teng, et al.
European Journal of Heart Failure|April 4, 2020
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failureIziah E Sama, Rebecca J Woolley, Jan F Nauta, et al.
European Journal of Heart Failure|February 5, 2024
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approachBart J van Essen, Ganash N Tharshana, Wouter Ouwerkerk, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2025
Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart FailureKees H van Bergeijk, Constantijn S Venema, Bob Ophuis, et al.
European Journal of Heart Failure|September 10, 2023
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF modelPascal M Burger, Gianluigi Savarese, Jasper Tromp, et al.
Circulation. Heart Failure|April 16, 2024
Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry ScienceAnubha Agarwal, Jasper Tromp, Wael Almahmeed, et al.
European Journal of Heart Failure|August 9, 2024
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registryThong Huy Cao, Wan Ting Tay, Donald J L Jones, et al.
Pageof 20